HOME >> BIOLOGY >> NEWS
No need to thank dinosaur-killing asteroid for mammalian success

Athens, Ga. -- It is a natural history tale that every third grader knows: The dinosaurs ruled the Earth for hundreds of millions of years, until an asteroid struck the Yucatan Peninsula and triggered a mass extinction that allowed the ancestors of todays mammals to thrive.

The asteroid part of the story may still hold true, but a new study published in the March 29 issue of the journal Nature challenges the prominent hypothesis that a mass extinction of dinosaurs 65 million years ago played a major role in the diversification of todays mammals.

An international team of scientists including University of Georgia Institute of Ecology Director John Gittleman has constructed a complete evolutionary tree for mammals that puts the major diversification well after asteroid strike, casting into doubt the role the dinosaur die-off played in the success of mammals.

"The previous evidence showed that we did see a die-off of the dinosaurs and an increase in the rise of the mammals roughly 65 million years ago," Gittleman said. "But the fossil record, by its very nature, is patchy. We have found that when you fuse all of the molecular trees with the fossil evidence, the timing does not work. The preponderance of mammals really didnt take off until 10 to 15 million years after the demise of the dinosaurs."

Molecular evolutionary trees are constructed by comparing the DNA of species. Because genetic changes occur at a relatively constant rate, like the ticking of a clock, scientists can estimate the time the species diverged from their common ancestor by counting the number of mutations. Using radiocarbon dating, scientists can also estimate divergence times from the fossil record. Gittleman and his colleagues combined more than 2,500 partial trees constructed using molecular data and the fossil record to create the first virtually complete mammalian tree.

"The end result is that the mammals we know today are actually quite ol
'"/>

Contact: Sam Fahmy
sfahmy@uga.edu
706-542-5361
University of Georgia
28-Mar-2007


Page: 1 2 3

Related biology news :

1. Madagascan tropical forests return thanks to better management and well-defined ownership
2. Human proteins evolving slowly thanks to multitasking genes
3. An artificial cornea is in sight, thanks to biomimetic hydrogels
4. Pregnant drivers, football players safer thanks to a top Virginia Tech researcher
5. Producing flu vaccines will be faster and cheaper, thanks to MSU technology
6. Diabetes research takes wing thanks to long-lived fruit fly
7. Free access to world-class biological databases for European science thanks to FELICS
8. Give thanks for the cranberry, say dental researchers
9. No blind mice, thanks to UF scientists
10. New evidence indicates biggest extinction wasnt caused by asteroid or comet
11. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: need thank dinosaur killing asteroid for mammalian success

(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: